05
Mar

In this week’s EuroBiotech Report, an investment vehicle backed by the megarich family that founded Serono plans to merge Stallergenes with Greer to create a transatlantic allergy immunotherapy player that can go toe-to-toe with Circassia and Merck. Cerenis Therapeutics has big plans of its own. And more.

…read more

Source: Billionaires plot Stallergenes merger, Cerenis set for IPO, Big Pharma-backed Opsona eyes IPO

    

0 No comments